Personal information

No personal information available

Activities

Employment (3)

Novartis : Basel, CH

2019-12-01 to present | Senior Principal Scientist (NIBR)
Employment
Source: Self-asserted source
David Andreas Schubert

F. Hoffmann-La Roche: Basel, CH

2016-01-01 to 2019-11-30 | Principal Sceintist (I2O)
Employment
Source: Self-asserted source
David Andreas Schubert

UCB Celltech: Slough, Berkshire, GB

2012-02-01 to 2015-12-31
Employment
Source: Self-asserted source
David Andreas Schubert

Education and qualifications (2)

Dana-Farber Cancer Institute: MA, MA, US

2005-05-01 to 2011-12-21 | postdoctoral fellow (Cancer Immunology and AIDS)
Education
Source: Self-asserted source
David Andreas Schubert

Deutsches Rheuma-Forschungszentrum Berlin: Berlin, Berlin, DE

2001-09-01 to 2005-04-30 | PhD student
Qualification
Source: Self-asserted source
David Andreas Schubert

Works (14)

Tissue-Specific Immunoregulation: A Call for Better Understanding of the "Immunostat" in the Context of Cancer.

Cancer discovery
2018-03-15 | Journal article
Source: Self-asserted source
David Andreas Schubert

Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.

Advanced healthcare materials
2017-01-24 | Journal article
Source: Self-asserted source
David Andreas Schubert

Cellular Innate Immunity: An Old Game with New Players.

Journal of innate immunity
2016-12-23 | Journal article
Source: Self-asserted source
David Andreas Schubert

Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.

Nature communications
2013-01-01 | Journal article
Source: Self-asserted source
David Andreas Schubert

Local changes in lipid environment of TCR microclusters regulate membrane binding by the CD3ε cytoplasmic domain.

The Journal of experimental medicine
2012-11-19 | Journal article
Source: Self-asserted source
David Andreas Schubert

Self-reactive human CD4 T cell clones form unusual immunological synapses.

The Journal of experimental medicine
2012-02-06 | Journal article
Source: Self-asserted source
David Andreas Schubert

A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.

The Journal of experimental medicine
2011-01-03 | Journal article
Source: Self-asserted source
David Andreas Schubert

HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Nature immunology
2010-12-05 | Journal article
Source: Self-asserted source
David Andreas Schubert

Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.

Arthritis research & therapy
2005-09-20 | Journal article
Source: Self-asserted source
David Andreas Schubert

The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.

Arthritis research & therapy
2004-11-30 | Journal article
Source: Self-asserted source
David Andreas Schubert

Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis.

Annals of the rheumatic diseases
2004-04-01 | Journal article
Source: Self-asserted source
David Andreas Schubert

Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.

Journal of immunology (Baltimore, Md. : 1950)
2004-04-01 | Journal article
Source: Self-asserted source
David Andreas Schubert

Autoantibodies to GPI and creatine kinase in RA.

Nature immunology
2002-05-01 | Journal article
Source: Self-asserted source
David Andreas Schubert

Species-specific, postentry barriers to primate immunodeficiency virus infection.

Journal of virology
1999-12-01 | Journal article
Source: Self-asserted source
David Andreas Schubert